| Author
Year | N | Location of primary tumor | Number of
gastrinomas | Treatment | Clinical response
(overall)
N (%)* | Biochemical
response
N (%)* | Radiological response* |
| Sato et al.,
2000 [13] | 2
| pNET | NS | TAE | NS | 100% | NS |
| Mitty et al.,
1985 [14] | 18
| Carcinoid, pNET, lung, unknown | NS | TAE | 17 (94%) | 12 (67%) | NS |
| Kamat et al.,
2008 [15] | 38 | pNET, carcinoid | NS | TAE
TACE | 20 (53%) | NS | 15 (44%) |
| Strosberg et al.,
2006 [16] | 84 | Carcinoid, unknown, lung | NS | TAE | 44 (52%) | 35 (42%) | 40 (48%) |
| Meij et al.,
2005 [17] | 13 | pNET, carcinoid | NS | TAE | 4 (31%) | 3 (23%) | 4 (31%) |
| Chamberlain et al.,
2000 [18] | 33 | pNET, carcinoid | NS | TAE | 31 (94%) | NS | NS |
| Marlink et al.,
1990 [19] | 10 | pNET, carcinoid | NS | TAE | 10 (100%) | 10 (100%) | 10 (100%) |
| Stockmann et al.,
1984 [20] | 6 | pNET, carcinoid | NS | TAE | 6 (100%) | 6 (100%) | NS |
| Gupta et al.,
2005 [21] | 123 | pNET, carcinoid, lung, unknown | 9 | TAE
TACE | NS | NS | 67% carcinoid
35% pNET |
| Osborne et al.,
2006 [22] | 59
| Carcinoid, pNET, unknown, lung | 2 | TAE | 48 (81%) | NS | NS |
| Ajani et al.,
1988 [23] | 22
| pNET | 9 | TAE | 12 (55%) | 12 (55%) | NS |
| Brown et al.,
1999 [24] | 35 | pNET, carcinoid
| 4 | TAE | 10 (29%) | 12 (34%)
| 12 (34%) |
| Eriksson et al.,
1998 [25] | 41 | pNET, carcinoid | 2 | TAE | NS | 16 (40%) | 38% carcinoid
17% pNET |
| | Jilesen, present study | 3 | Gastrinomas | 3 | TAE | 3 (100%) | 2 (67) | 3 (100%) |
|
|
